Torrent Pharma gains after inking pact to acquire majority stake in JB Chemicals & Pharma
Shares of JB Chemicals & Pharmceuticals declined 6.63% to Rs 1,680.05 on the BSE.
The acquisition would provide access to a fast growing India franchise, with leading brands in the chronic segment, and entry into untapped therapeutic areas like ophthalmology. It strengthens market share in the IPM for Torrent and offers operational synergies across multiple business functions.
The deal also supports platform diversification through entry into the CDMO segment with long-term potential. Additionally, it facilitates consolidation in key international markets and greater ability to scale up.
The transaction will be executed in two phases. In first phase, the company will acquire 7,44,81,519 equity shares, representing a 46.39% stake at Rs 1,600 per share, for a total consideration of Rs 11,917 crore from the promoter seller, KKR.
Additionally, the company plans to acquire up to 44,99,782 shares, representing a 2.80% stake at the same price of Rs 1,600 per share, from certain employees of JB Chemicals & Pharmaceuticals. Furthermore, the company will launch an open offer to acquire 4,17,45,264 equity shares or 26% stake at Rs 1,639.18 per share from public shareholders of JB Chemicals & Pharmaceuticals.
In second phase, the company will merge with JB Pharma through a scheme of arrangement. As per the approved by the board of directors of both companies, shareholders of JB Pharma will receive 51 shares of Torrent for every 100 shares held in JB Pharma upon completion of the merger.
Samir Mehta executive chairman, Torrent, commented: We are pleased to have on board the JB Pharma heritage and build on the platform for the future. Torrents deep India presence and JB Pharmas fast growing India business, combined with the CDMO and international footprint offers immense potential to scale both revenue and profitability. This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market, and build a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.
Gaurav Trehan, co-head of Asia Pacific and head of Asia Pacific Private Equity, KKR, and CEO of KKR India, said: JB Pharmas transformation under our stewardship is a testament to KKRs ability to scale high-quality companies. We are proud to have collaborated with JB Pharmas management team, led by Nikhil Chopra, to bring the breadth of KKRs global experience and operational expertise to support the companys organic and inorganic growth, and help JB Pharma become one of Indias fastest growing branded pharmaceutical companies. We believe the company is well-positioned for continued growth ahead and wish the team every success in its next chapter with Torrent.
Torrent Pharma is the flagship company of the Torrent Group. It is amongst the Top 5 in the therapeutics segments of Cardiovascular (CV), Gastro Intestinal (GI), Central Nervous System (CNS) and Cosmo-Dermatology. It has 8 manufacturing facilities, of which 5 are USFDA approved.
J.B. Chemicals & Pharmaceuticals is a public listed company primarily engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
30 minutes ago
- Business Standard
Borosil Renewables to wind up German unit, focus on Indian solar glass
Borosil Renewables has filed an application to wind up operations of its German subsidiary to sharpen focus on the Indian solar glass market with immense potential. In a regulatory filing, Borosil Renewables Ltd said its material step-down subsidiary in Germany, GMB Glasmanufaktur Brandenburg GmbH, has filed an application for the commencement of insolvency proceedings before the Insolvency Court at Cottbus, Germany, in accordance with the German Insolvency Code (InsO). This decision was reached after a comprehensive assessment of market conditions, financial viability, and long-term strategic priorities. "The challenges for GMB began with slide in demand for German made solar panels, when faced with the precipitous drop in prices by Chinese manufacturers of solar panels, who have engaged in large scale dumping in the European market, using predatory pricing. "Despite the alarms sounded by the German solar module manufacturers seeking protection against such dumping, policy responses to date have been insufficient," the filing said. Lack of meaningful protective measures by the authorities concerned has led to the shutdown of major solar module manufacturers in Germany, with some of them filing for the commencement of insolvency proceedings. Eventually, this resulted in the disappearance of the market demand for solar glass manufactured by GMB, causing substantial losses to GMB, which has affected the consolidated financials of the company, it said. The company/GMB has approached the authorities concerned to get some quick measures in place. GMB (capacity of 350 tonnes per day) was once a vital part of Borosil's global footprint, serving the European solar glass market. However, since the second half of 2023, the landscape changed dramatically. A significant increase in low-cost solar panel imports from China created unprecedented pricing pressure, leading to a rapid decline in demand for German-made modules and, consequently, for locally produced solar glass. Lack of meaningful protective measures by the authorities has led to the shutdown of major solar module manufacturers in Germany, with some of them filing for the commencement of insolvency proceedings. As of March 31, 2025, Borosil's total exposure to GMB and its associated German entities stood at 35.30 million euros, or approximately ₹340 crore. This includes both capital investments and loans extended over time to sustain German operations. From the date of the insolvency filing (July 4, 2025), Borosil will no longer account for GMB's monthly losses. Analysts said the insolvency filing will lead to sharper focus on Indian operations that are witnessing significant tailwinds. The move allows Borosil Renewables to halt capital bleed in a structurally declining market and reallocate resources toward its growth nucleus: India. India presents a compelling growth story driven by sizeable addition to solar power capacity every year, strong demand for solar infrastructure, supportive government policy (including PLI schemes and ALMM for modules and cells), and a favourable cost base. Manufacturing capacity for solar modules has already reached 90-plus gigawatts and is expected to rise to 150 gigawatts by March 2027. Thus, there is a huge scope for capacity addition and import substitution. With this pivot, Borosil aims to double down on its leadership in solar glass innovation, manufacturing scale, and ESG-driven clean energy technologies, they said. In May this year, Borosil Renewables announced its plan to raise production capacity for solar glass by 600 tonnes per day, by setting up two furnaces of 300 TPD each at an estimated cost of ₹950 crore. This translates into significant capacity addition of 60 per cent, considering Borosil's existing manufacturing capacity of 1,000 TPD. The imposition of anti-dumping duty for a period of five years, effective from December 4, 2024, on the import of solar glass from China and Vietnam is leading to a level playing field for domestic manufacturers. This policy measure is anticipated to foster rapid and significant growth in domestic solar glass manufacturing. The imposition of anti-dumping duty has also led to a significant improvement in domestic prices for solar cells. For example, average ex-factory selling prices for solar glass during Q4 FY25 were about ₹127.6 per millimetre per square metre as compared to ₹99.6 per millimetre per square metre in the same period in FY24, translating into an increase of 28 per cent. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Time of India
35 minutes ago
- Time of India
Signature Global buys 2 land parcels in Gurugram totalling 10 acres for housing projects
Realty firm Signature Global has acquired two land parcels in Gurugram totalling 10 acres to build housing projects. Signature Global's subsidiary firm has executed two sale deeds to purchase the lands admeasuring approximately 9.96 acres situated at Tehsil Sohna, District Gurugram, Haryana. These lands have an overall potential sales area of approximately 0.53 million (5.3 lakh) square feet, according to a recent regulatory filing. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Fungo nas unhas: um truque simples reduz facilmente Acabe com os Fungo Undo Last month, Signature Global chairman Pradeep Kumar Aggarwal said the company would invest around Rs 1,200-1,500 crore to acquire land parcels as part of its expansion plan. Signature Global had invested Rs 1,070 crore last fiscal year to purchase 48 acres of land in Gurugram, Haryana. Live Events "Land is an important raw material for real estate developers. We will be investing around Rs 1,200-1,500 crore on the acquisition of land parcels this fiscal," he had said. Signature Global emerged as the fifth largest listed real estate developer last fiscal in terms of sales bookings by achieving record pre-sales of Rs 10,290 crore. The Gurugram-based company has given a guidance of posting Rs 12,500 crore worth pre-sales in the current fiscal. Signature Global is also ramping up construction activities across its ongoing projects. The company will invest Rs 2,500 crore in 2025-26 fiscal on construction activities as against Rs 1,900 crore in the preceding fiscal. Recently, Signature Global announced plans to raise Rs 875 crore through issue of non-convertible debentures to refinance debt and expand business . Signature Global started its business to develop affordable housing projects but shifted its focus on mid-income, premium and luxury segments because of high land cost in Gurugram. During the last fiscal year, the company posted a net profit of Rs 101.2 crore, a sharp jump from Rs 16.32 crore in the preceding year. Its total income grew to Rs 2,637.99 crore in the last fiscal from Rs 1,324.55 crore in 2023-24. Since inception, Signature Global has delivered 13.5 million sq ft of housing projects and has a strong pipeline of about 21.6 million sq ft of saleable area in upcoming projects, along with 46.38 million sq ft of ongoing projects, targeted for completion within the next 2-3 years.
Hans India
42 minutes ago
- Hans India
Adani Enterprises announces Rs 1,000 crore NCDs offering up to 9.30 pc, issue opens July 9
Adani Enterprises Limited (AEL) on Sunday announced the launch of its second public issuance of secured, rated and listed redeemable, non-convertible debentures (NCD) worth Rs 1,000 crore. The issue opens on July 9 and closes on July 22 (with an option of early closure or extension), offering up to 9.30 per cent per annum. The NCDs have a face value of Rs 1,000 each. Each application will be for a minimum of 10 NCDs and in multiples of 1 NCD thereafter. The minimum application size would be Rs 10,000. The NCDs offer competitive yields compared to similarly rated NCDs and fixed deposits and are proposed to be listed on the BSE and the NSE. The proposed NCDs have been rated "Care AA-; Stable" and "(ICRA) AA- (Stable)", according to the company. AEL's first NCD issuance of Rs 800 crore, launched in September last year, was fully subscribed on the first day. "The second public issuance of NCDs by AEL further deepens our commitment to inclusive capital markets growth and retail participation in long-term infrastructure development. This new issuance follows the strong market response to AEL's debut NCD offering, which witnessed capital appreciation for debt investors after a rating upgrade within six months, reflecting the Group's consistent delivery and financial robustness," said Jugeshinder 'Robbie' Singh, Group CFO, Adani Group. As the incubator of India's most critical energy and transport utility platforms, including Adani Ports & SEZ, Adani Energy Solutions, Adani Power, and Adani Green Energy, AEL is now successfully scaling the next generation of infrastructure businesses across airports, roads, data centres, and the green hydrogen ecosystem, he added. "Each of these verticals is poised to play a transformative role in India's journey toward a $5 trillion economy," Singh noted. At least 75 per cent of the proceeds from the issuance will be utilised towards the prepayment or repayment, in full or in part, of the existing indebtedness availed by the company, and the balance (up to a maximum of 25 per cent) for general corporate purposes. The NCDs are available in tenors of 24 months, 36 months, and 60 months with quarterly, annual and cumulative interest payment options across eight series, said the company. The base size issue is Rs 500 crore, with an option to retain over-subscription up to an additional Rs 500 crore (Green Shoe Option), aggregating up to Rs 1,000 crore, according to the flagship company of the Adani Group and India's largest listed business incubators in terms of market capitalisation. AEL is the only corporate (outside of NBFCs) offering a listed debt product for retail investors, thereby creating a rare opportunity for individual and non-institutional investors to participate in India's infrastructure growth story. With the recent rate cuts and the beginning of a softer interest rate cycle, the AEL NCD issue comes at an opportune time for investors seeking stable, fixed-income avenues. Offering competitive yields compared to similarly rated NCDs and fixed deposits, this public issue presents a valuable proposition for investors. CARE Ratings first upgraded the credit rating of AEL on February 19, 2025 and reaffirmed the rating on June 18.
